Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|23|2955-2964

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.23, 2013-12, pp. : 2955-2964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 503-507

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt/&bgr;-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 716-727

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 701-709

Bentham Science Publishers

Access to resources Recommend Favorite

14-3-3ζ as a prognostic marker and therapeutic target for cancer

By Neal Christopher L   Yu Dihua  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1343-1354

Informa Healthcare

Access to resources Recommend Favorite

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia

By Balakrishnan Kumudha   Gandhi Varsha  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 409-423

Informa Healthcare

Access to resources Recommend Favorite